Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis

Journal of Hepatology

Volumn 36, Issue 6, 2002, Pages 751-758

  Donaghy, Anthony J ^a   Delhanty, Patric J D ^a   Ho, Ken K ^b   Williams, Roger ^c   Baxter, Robert C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cirrhosis; Hepatocyte; Insulin like growth factor I bioavailability; Liver; Ternary complex

Indexed keywords

BINDING PROTEIN; GROWTH HORMONE RECEPTOR; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HORMONE BINDING; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER CIRRHOSIS; MALE; MICROSOME MEMBRANE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSCRIPTION REGULATION;

ADOLESCENT; AGED; BLOTTING, NORTHERN; CARRIER PROTEINS; COHORT STUDIES; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RECEPTORS, SOMATOTROPIN;

EID: 0036623365     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00049-1     Document Type: Article

References (52)

1. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983;113:297-305.
2. Baxter RC. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab 1993;4:91-96.
3. Baxter RC. Circulating levels and molecular distribution of the acid labile subunit of the high molecular weight growth factor-binding protein complex. J Clin Endocrinol Metab 1990;70:1347-1353.
4. Twigg SM, Baxter RC. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J Biol Chem 1998;273:6074-6079.
5. Jones IJ, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 1995;16:3-34.
6. Cuneo RC, Hickman PE, Wallace JD, Teh BT, Ward G, Veldhuis JD, et al. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin Endocrinol 1995;43:265-275.
7. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulinlike growth factor-I, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995;21:680-688.
8. Moller S, Becker U, Juul A, Skakkebaek NE, Christensen E. Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver disease. Hepatology 1996;23:1073-1078.
9. Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol 1997;27:796-802.
10. Mendenhall CL, Chernhausek SD, Ray MB, Gartside PS, Roselle GA, Grossman CJ, et al. The interactions of insulin-like growth factor-I (IGF-1) with protein-calorie malnutrition in patients with alcoholic liver disease: V.A. Cooperative study on Alcoholic Hepatitis VI. Alcohol Alcoholism 1989;24:319-329.
11. Shmueli E, Miell JP, Stewart M, Alberti KG, Record CO. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. Hepatology 1996;24:127-133.
12. Mendenhall CL, Roselle GA, Gartside P, Grossman CJ. Effects of recombinant human insulin-like growth factor-I and recombinant human growth hormone on anabolism and immunity in calorie-restricted alcoholic rats. Alcohol Clin Exp Res 1997;21:1-10.
13. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695-699.
14. Cemborain A, Castilla-Cortazar I, Garcia M, Quiroga J, Muguerza B, Picardi A, et al. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol 1998;28:122-131.
15. Picardi A, Costa de Oliveira A, Muguerza B, Tosar A, Quiroga J, Castilla CI, et al. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol 1997;26:191-202.
16. Castilla CI, Garcia M, Muguerza B, Quiroga J, Perez R, Santidrian S, et al. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 1997;113:1682-1691.
17. Chang TC, Lin JJ, Yu SC, Chang TJ. Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver. Hepatology 1990;11:123-126.
18. Donaghy A, Ross R, Wicks C, Hughes SC, Holly J, Gimson A, et al. Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety. Gastroenterology 1997;113:1617-1622.
19. Pugh RN, MurrayLyon IM, Dawson JL, Dietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
20. Rajkovic IA, Valiontis E, Ho KK. Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatographic methods. J Clin Endocrinol Metab 1994;78:772-777.
21. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1995;80:2700-2708.
22. Chomczynski P, Saachi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Delhanty PJ, Baxter RC. The regulation of acid-labile subunit gene expression and secretion by cyclic adenosine 3′,5′-monophosphate. Endocrinology 1998;139:260-265.
24. Baxter RC, Turtle JR. Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun 1978;84:350-357.
25. Zhang J, Chrysis D, Underwood LE. Reduction of hepatic insulin-like growth factor I (IGF-I) messenger ribonucleic acid (mRNA) during fasting is associated with diminished splicing of IGF-I pre-mRNA and decreased stability of cytoplasmic IGF-I mRNA. Endocrinology 1998;139:4523-4530.
26. Shen XY, Holt RI, Miell JP, Justice S, Portmann B, Postel-Vinay MC, et al. Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors. J Clin Endocrinol Metab 1998;83:2532-2538.
27. Holt RI, Crossey P, Jones JS, Baker AJ, Portmann B, Miell JP. Hepatic growth hormone receptor, insulin-like growth factor I and insulin-like growth factor binding protein messenger RNA expression in paediatric liver disease. Hepatology 1997;26:1600-1606.
28. Chin E, Zhou J, Baxter R, Bondy C. Cellular localisation and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994;134:2498-2504.
29. Assaad SN, Cunningham GR, Samaan NA. Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease. Metabolism 1990;39:349-356.
30. Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 1995;80:1148-1157.
31. Baruch Y, Amit T, Hertz P, Enat R, Youdim MB, Hochberg Z. Decreased serum growth hormone-binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 1991;73:777-780.
32. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987;330:537-543.
33. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J. Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 1993;132:1863-1865.
34. Mullis PE, Holl RW, Lund T, Eble A, Brickell PM. Regulation of human growth hormone-binding protein production by human growth hormone in a hepatoma cell line. Mol Cell Endocrinol 1995;111:181-190.
35. Rasmussen MH, Ho KK, Kjems L, Hilsted J. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss. J Clin Endocrinol Metab 1996;81:1519-1524.
36. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999;96:7324-7329.
37. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 1986;83:9343-9347.
38. Kratzsch J, Blum WF, Schenker E, Keller E, Jahreis G, Haustein B, et al. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay. Exp Clin Endocrinol 1993;101:144-149.
39. Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M. Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 1995;80:374-378.
40. Holt RI, Crossey PA, Jones JS, Baker AJ, Portmann B, Miell JP. Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease. Hepatology 1997;26:1600-1606.
41. Moller S, Juul A, Becker U, Henriksen JH. The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis: relation to liver dysfunction. J Hepatol 2000;32:441-446.
42. Delhanty PJ, Baxter RC. Cloning and characterization of the rat gene for the acid-labile subunit of the insulin-like growth factor binding protein complex. J Mol Endocrinol 1997;19:267-277.
43. Ooi GT, Cohen FJ, Tseng LY, Rechler MM, Boisclair YR. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver. Mol Endocrinol 1997;11:997-1007.
44. Ooi GT, Hurst KR, Poy MN, Rechler MM, Boisclair YR. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Mol Endocrinol 1998;12:675-687.
45. Scott CD, Baxter RC. Synthesis of the acid-labile subunit of the growth-hormone-dependent insulin-like-growth-factor-binding protein complex by rat hepatocytes in culture. Biochem J 1991;275:441-446.
46. Dai J, Scott CD, Baxter RC. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 1994;135:1066-1072.
47. Dai J, Baxter RC. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology 1994;135:2335-2341.
48. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJ, Hill DJ. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994;79:1871-1876.
49. Ross RJ, Chew SL, D'Souza LL, Yateman M, Rodriguez AJ, Gimson A, et al. Expression of IGF-I and IGF-binding protein genes in cirrhotic liver. J Endocrinol 1996;149:209-216.
50. Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol 1989;121:753-758.
51. Lewitt MS, Saunders H, Phuyal JL, Baxter RC. Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology 1994;134:2404-2409.
52. Scharf J, Schmitz F, Frystyk J, Skjaerbaek C, Moesus H, Blum W, et al. Insulin-like growth factor-I serum concentrations and patterns of Insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996;25:689-699.